What is PLSE's earnings growth forecast for 2026-2026?
(NASDAQ: PLSE) Pulse Biosciences's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Instruments & Supplies industry's average forecast earnings growth rate of N/A, and while it is not forecast to beat the US market's average forecast earnings growth rate of N/A.
Pulse Biosciences's earnings in 2026 is -$74,733,000.
In 2026, PLSE is forecast to generate -$114,744,063 in earnings, with the lowest earnings forecast at -$110,244,296 and the highest earnings forecast at -$118,118,888.
What is PLSE's revenue growth forecast for 2026-2026?
(NASDAQ: PLSE) Pulse Biosciences's forecast annual revenue growth rate of N/A is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of N/A, and while it is not forecast to beat the US market's average forecast revenue growth rate of N/A.
Pulse Biosciences's revenue in 2026 is $86,000.
In 2026, PLSE is forecast to generate $259,210,986 in revenue, with the lowest revenue forecast at $249,045,849 and the highest revenue forecast at $266,868,722.
What is PLSE's forecast return on assets (ROA) for 2026-2026?
(NASDAQ: PLSE) forecast ROA is -105.5%, which is lower than the forecast US Medical Instruments & Supplies industry average of 12.57%.
What is PLSE's Earnings Per Share (EPS) forecast for 2026-2026?
(NASDAQ: PLSE) Pulse Biosciences's current Earnings Per Share (EPS) is -$1.14. In 2026, PLSE's EPS is forecast to hit -$1.69 (min: -$1.63, max: -$1.74).
What is PLSE's forecast return on equity (ROE) for 2026-2026?
(NASDAQ: PLSE) forecast ROE is -123.79%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.